BrainTech - The Next Big Opportunity - Learn from a VC
About the Session
Discover the untapped potential of the brain! Did you know that nearly 40% of the global population lives with neurological dysfunction? This session dives into the fascinating world of BrainTech and NeuroTech, revealing how venture capital operates within this vital field. Expect jargon demystified and no question too basic!
Who Should Attend
- Anyone intrigued by investing in emerging VC sectors.
- Professionals wanting to understand the inner workings of venture capital.
- Those curious about limited partners and how money flows behind the scenes.
- Clinicians, scientists, and innovators interested in the convergence of neuroscience and technology.
What You Will Gain
- A clear understanding of fund structures, the role of LPs, and concepts like check sizes, valuations, and dilution.
- Insight into FDA-approved technologies and current funding trends within BrainTech/NeuroTech.
- Engaging Q&A session, plus lunch and networking opportunities!
Agenda
- 12:00 PM: Doors open. Lunch served.
- 12:10 PM: Welcome and Daybreak Labs overview. Discussion on why the brain is the least mapped medical system and implications for healthcare.
- 12:20 PM: Venture Capital 101: Fund structures, LPs, check sizes, valuations, dilution, and getting deals done.
- 12:40 PM: From Science to Market: Understanding what neurotech is delivering and how investors discern investable ideas.
- 12:55 PM: Open Q&A session—where no question is too basic.
- 1:15 PM: Networking with founders and innovators from the Daybreak Labs community. Event closes at 1:30 PM.
Speaker
Varun Turlapati
Managing Director, Chaanakya Capital
From manual QA testing to leading a venture fund, Varun has a unique perspective on BrainTech and NeuroTech. He invests in crucial areas often overlooked by others, and his straightforward approach to venture capital is refreshing.
Note
This event is supported by Daybreak Labs / i-GATE Innovation Hub, aiming to bolster the Tri-Valley innovation and investment community. i-GATE does not endorse, nor make representations regarding the investment merits of Chaanakya Capital or its offerings.
👉 RSVP Here — Limited spots available!
